AR007828A1 - Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos - Google Patents

Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos

Info

Publication number
AR007828A1
AR007828A1 ARP970103050A ARP970103050A AR007828A1 AR 007828 A1 AR007828 A1 AR 007828A1 AR P970103050 A ARP970103050 A AR P970103050A AR P970103050 A ARP970103050 A AR P970103050A AR 007828 A1 AR007828 A1 AR 007828A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
piridilpirrol
same
compositions containing
preparation procedure
Prior art date
Application number
ARP970103050A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR007828A1 publication Critical patent/AR007828A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Un compuesto derivado de piridil pirrol de fórmula (I) y sus sales farmacéuticamente aceptables, donde R1, R2, R3, R4, R5 y m son tal como sedefinen en la reivindicación 1. También aporta procedimientos para la preparación delmis mo, útil en el tratamiento de enfermedades en las queintervienen moléculas de adhesión celular (CAMs) y composiciones farmacéuticas para usarse en tal terapia.
ARP970103050A 1996-07-11 1997-07-08 Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos AR007828A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9600671 1996-07-11

Publications (1)

Publication Number Publication Date
AR007828A1 true AR007828A1 (es) 1999-11-24

Family

ID=11004451

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103050A AR007828A1 (es) 1996-07-11 1997-07-08 Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos

Country Status (14)

Country Link
US (1) US6417202B1 (es)
EP (1) EP0912548A1 (es)
AP (1) AP9701041A0 (es)
AR (1) AR007828A1 (es)
AU (1) AU3044197A (es)
BR (1) BR9710352A (es)
CA (1) CA2260213C (es)
HN (1) HN1997000090A (es)
HR (1) HRP970378A2 (es)
ID (1) ID19476A (es)
MA (1) MA26433A1 (es)
PA (1) PA8432901A1 (es)
TN (1) TNSN97119A1 (es)
WO (1) WO1998002430A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945418A (en) * 1996-12-18 1999-08-31 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US6147080A (en) * 1996-12-18 2000-11-14 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US6608060B1 (en) 1996-12-18 2003-08-19 Vertex Pharmaceuticals Incorporated Inhibitors of p38
PT853083E (pt) * 1997-01-06 2001-12-28 Pfizer Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
FR2771412B1 (fr) * 1997-11-26 2000-04-28 Adir Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1057485B1 (en) * 1998-01-14 2005-05-11 Nippon Shinyaku Co., Ltd. Potassium channel activators
AU3953899A (en) * 1998-05-27 1999-12-13 Nippon Shinyaku Co. Ltd. Cyclooxygenase-2 inhibitors
WO2000066124A1 (fr) * 1999-04-28 2000-11-09 Sankyo Company, Limited Agents preventifs ou inhibiteurs destines a une hepatopathie
KR20010114267A (ko) * 1999-05-14 2001-12-31 오르토-맥네일 파마슈티칼, 인코퍼레이티드 치환된 3-피리딜-4-아릴피롤과 관련 치료방법 및 예방방법
CN1414951A (zh) * 1999-10-28 2003-04-30 基本治疗公司 药剂排出泵抑制药
GB0003154D0 (en) 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
GB0016453D0 (en) * 2000-07-04 2000-08-23 Hoffmann La Roche Pyrrole derivatives
KR20030076612A (ko) * 2001-01-18 2003-09-26 상꾜 가부시키가이샤 간장해를 예방 또는 치료하기 위한 조성물
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
CA2665516A1 (en) * 2001-04-26 2002-11-07 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
SE0102617D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0102616D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
DE60207273T2 (de) 2001-08-30 2006-07-20 F. Hoffmann-La Roche Ag Aminopyrrolverbindungen als entzündungshemmende Wirkstoffe
AU2003297431A1 (en) * 2002-12-20 2004-07-22 Pharmacia Corporation Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
SE0300091D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300092D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US20050043346A1 (en) * 2003-08-08 2005-02-24 Pharmacia Italia S.P.A. Pyridylpyrrole derivatives active as kinase inhibitors
EP1729776A1 (en) * 2004-02-20 2006-12-13 AstraZeneca AB Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
BRPI0620079A2 (pt) * 2005-12-19 2011-11-01 Syngenta Ltd compostos heterocìclicos aromáticos substituìdos como fungicidas
US7618982B2 (en) * 2005-12-19 2009-11-17 Nerviano Medical Sciences S.R.L. Heteroarylpyrrolopyridinones active as kinase inhibitors
UA94097C2 (ru) * 2006-03-27 2011-04-11 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Пиридил- и пиримидинилзамещенные производной пиррола, тиофена и фурана как ингибиторы киназ
EP2069333A1 (en) 2006-09-21 2009-06-17 Novartis Ag Pyrrole derivatives useful for the treatment of cytokine-mediated diseases
CN104379573A (zh) * 2012-04-20 2015-02-25 艾伯维公司 异吲哚酮衍生物
EP2838881B1 (en) 2012-04-20 2018-08-08 AbbVie Inc. Isoindolone derivatives
WO2014165127A1 (en) * 2013-03-12 2014-10-09 Abbvie Inc. Pyrrole amide inhibitors
ES2708211T3 (es) 2014-06-17 2019-04-09 Bayer Pharma AG 3-amino-1,5,6,7-tetrahidro-4H-indol-4-onas
JP2019504826A (ja) * 2015-12-16 2019-02-21 バイエル ファーマ アクチエンゲゼルシャフト ヘテロ−１，５，６，７−テトラヒドロ−４ｈ−インドール−４−オン類

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356897A (en) 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
DE69627006T2 (de) * 1995-08-10 2004-01-15 Merck & Co Inc 2-substituierte aryl-pyrrolen, zusammensetzungen solche verbindungen enthaltend und deren verwendung
AU699148B2 (en) * 1995-08-10 1998-11-26 Merck & Co., Inc. 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
WO1997016442A1 (en) 1995-10-31 1997-05-09 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
WO1997016441A1 (en) * 1995-10-31 1997-05-09 Merck & Co., Inc. Substituted aryl pyrroles, compositions containing such compounds and methods of use
AU7529096A (en) 1995-10-31 1997-05-22 Merck & Co., Inc. Substituted aryl pyrroles, compositions containing such compounds and methods of use
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use

Also Published As

Publication number Publication date
WO1998002430A1 (en) 1998-01-22
CA2260213C (en) 2005-03-29
HRP970378A2 (en) 1998-08-31
TNSN97119A1 (fr) 2005-03-15
AP9701041A0 (en) 1999-01-10
ID19476A (id) 1998-07-16
AU3044197A (en) 1998-02-09
EP0912548A1 (en) 1999-05-06
CA2260213A1 (en) 1998-01-22
PA8432901A1 (es) 2000-05-24
BR9710352A (pt) 1999-08-17
MA26433A1 (fr) 2004-12-20
US6417202B1 (en) 2002-07-09
US20020049235A1 (en) 2002-04-25
HN1997000090A (es) 1997-12-26

Similar Documents

Publication Publication Date Title
PA8432901A1 (es) Compuestos de piridilpirrol
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
CO5180642A1 (es) Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
SE9903760D0 (sv) New compounds
SE9504661D0 (sv) New compounds
SE9904505D0 (sv) Novel compounds
ATE246190T1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
DE60045508D1 (de) Dalda-analoge und ihre verwendung
DK0934309T3 (da) Nye pyridylalkansyreamider som cytostatiske og immunosuppressive midler
SE9702564D0 (sv) New compounds
NO20020282D0 (no) Nytt difenylpiperidinderivat
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
SE9804212D0 (sv) Compounds
PT722319E (pt) Derivados de antraciclinona e a sua utilizacao no tratamento da amiloidose
AR026267A1 (es) Agentes heterociclicos citotoxicos.
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
SE0003476D0 (sv) Compounds
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
PT1109560E (pt) Compostos uteis como inidores de aicarft
SE9902551D0 (sv) Novel compounds
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
PT728138E (pt) Derivados de antraciclina
DE69330601D1 (de) Serotoninergische ergolin derivate
SE9504662D0 (sv) New compounds